With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the tria ...
Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that it was notified by the staff of the U.S. Securities and Exchange ...
Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating ...
Ionis Pharmaceuticals, Inc. partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority ...
Curiosity has detected a surprising variety of organic molecules on Mars, including compounds tied to the chemistry of life.
With recent FDA acceptance of the Phase 2amultidose portionof INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results